Additive effects of moderate drinking and obesity on serum γ-glutamyl transferase activity

American Journal of Clinical Nutrition

Volumn 83, Issue 6, 2006, Pages 1351-1354

  Puukka, Katri ^a,b   Hietala, Johanna ^a,b   Koivisto, Heidi ^a,b   Anttila, Petra ^a,b   Bloigu, Risto ^c   Niemelä, Onni ^a,b  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Ethanol; Lipid peroxidation; Obesity

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; ALCOHOL;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DRINKING BEHAVIOR; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; NORMAL HUMAN; OBESITY; BLOOD; DRUG EFFECT; ENZYMOLOGY; HEALTH SURVEY; LIPID PEROXIDATION; LIVER; METHODOLOGY; MIDDLE AGED;

ALCOHOL DRINKING; BODY MASS INDEX; ETHANOL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIPID PEROXIDATION; LIVER; MALE; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE;

EID: 33745625412     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/83.6.1351     Document Type: Article

References (42)

1. Anton RF, Lieber C, Tabakoff B. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 2002;26:1215-22.
2. Conigrave KM, Davies P, Haber P, Whitfield JB. Traditional markers of excessive alcohol use. Addiction 2003;98(suppl):31-43.
3. Niemelä O. Serum diagnosis of alcoholic liver disease and markers of ethanol intake. In: Sherman DIN, Preedy V, Watson RR, eds. Ethanol and the Liver. 1st ed. New York, NY: Taylor and Francis, 2002:411-49.
4. Zein M, Discombe G. Serum gamma-glutamyl transpeptidase as a diagnostic aid. Lancet 1970;2:748-50.
5. Bagrel A, d'Houtaud A, Gueguen R, Siest G. Relations between reported alcohol consumption and certain biological variables in an " unselected" population. Clin Chem 1979;25:1242-6.
6. Papoz L, Warnet JM, Pequignot G, Eschwege E, Claude JR, Schwartz D. Alcohol consumption in a healthy population. Relationship to gamma-glutamyl transferase activity and mean corpuscular volume. JAMA 1981;245:1748-51.
7. Chick J, Kreitman N, Plant M. Mean cell volume and gamma- glutamyltranspeptidase as markers of drinking in working men. Lancet 1981;1:1249-51.
8. Anttila P, Järvi K, Latvala J, Niemelä O. Method-dependent characteristics of carbohydrate-deficient transferrin measurements in the follow-up of alcoholics. Alcohol Alcohol 2004;39:59-63.
9. Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 2004;37:1018-23.
10. Conway B, Rene A. Obesity as a disease: no lightweight matter. Obes Rev 2004;5:145-51.
11. Halsted CH. Obesity: effects on the liver and gastrointestinal system. Curr Opin Clin Nutr Metab Care 1999;2:425-9.
12. Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005;365:519-30.
13. Colicchio P, Tarantino G, Del Genio F, et al. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann Nutr Metab 2005;49:289-95.
14. Daeppen JB, Smith TL, Schuckit MA. Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res 1998;22:941-4.
15. Lam GM, Mobarhan S. Central obesity and elevated liver enzymes. Nutr Rev 2004;62:394-9.
16. Lawlor DA, Sattar N, Smith GD, Ebrahim S. The associations of physical activity and adiposity with alanine aminotransferase and gamma- glutamyltransferase. Am J Epidemiol 2005;161:1081-8.
17. Peters TJ, Cook CC. Obesity as a cause of "false-positive" alcohol misuse laboratory investigations. Addict Biol 2002;7:443-6.
18. Rohrer JE, Rohland BM, Denison A, Way A. Frequency of alcohol use and obesity in community medicine patients. BMC Fam Pract 2005;6:17.
19. Stranges S, Dorn JM, Muti P, et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004;39:754-63.
20. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004;38:535-9.
21. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147-52.
22. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61.
23. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000;105:1067-75.
24. Niemelä O, Parkkila S, Juvonen RO, Viitala K, Gelboin HV, Pasanen M. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J Hepatol 2000;33:893-901.
25. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996;111:1645-53.
26. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128-33.
27. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19.
28. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 2005;19:136-8.
29. Diehl AM. Obesity and alcoholic liver disease. Alcohol 2004;34:81-7.
30. Niemelä O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic Biol Med 2001;31:1533-8.
31. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-19.
32. Kevil CG, Pruitt H, Kavanagh TJ, et al. Regulation of endothelial glutathione by ICAM-1: implications for inflammation. FASEB J 2004;18:1321-3.
33. Nakanishi N, Nakamura K, Suzuki K, Tatara K. Lifestyle and serum gamma-glutamyltransferase: a study of middle-aged Japanese men. Occup Med (Lond) 2000;50:115-20.
34. Speisky H, Shackel N, Varghese G, Wade D, Israel Y. Role of hepatic gamma-glutamyltransferase in the degradation of circulating glutathione: studies in the intact guinea pig perfused liver. Hepatology 1990;11:843-9.
35. Niemelä O, Parkkila S, Pasanen M, Viitala K, Villanueva JA, Halsted CH. Induction of cytochrome P450 enzymes and generation of protein-aldehyde adducts are associated with sex-dependent sensitivity to alcohol-induced liver disease in micropigs. Hepatology 1999;30:1011-7.
36. Wolbold R, Klein K, Burk O, et al. Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 2003;38:978-88.
37. Becker U, Grønbæk M, Johansen D, Sørensen TI. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002;35:868-75.
38. Bernadt MW, Mumford J, Taylor C, Smith B, Murray RM. Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet 1982;1:325-8.
39. Mundle G, Munkes J, Ackermann K, Mann K. Sex differences of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume in alcohol-dependent patients. Alcohol Clin Exp Res 2000;24:1400-5.
40. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
41. Anton RF, Moak DH. Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences. Alcohol Clin Exp Res 1994;18:747-54.
42. Orrego H, Blake JE, Blendis LM, Kapur BM, Israel Y. Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 1979;2:1354-6.